Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for InMode Ltd. (INMD : NSDQ)
 
 • Company Description   
InMode Ltd. is a provider of medical technologies. It develops, manufactures and markets devices harnessing novel radio-frequency technology. The company serves plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. InMode Ltd. is based in Yokneam, Israel.

Number of Employees: 362

 
 • Price / Volume Information   
Yesterday's Closing Price: $24.32 Daily Weekly Monthly
20 Day Moving Average: 2,934,701 shares
Shares Outstanding: 83.24 (millions)
Market Capitalization: $2,024.43 (millions)
Beta: 2.12
52 Week High: $99.27
52 Week Low: $20.60
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -20.00% -12.67%
12 Week -41.51% -36.79%
Year To Date -65.54% -59.19%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
TAVOR BUILDING SHAAR YOKNEAM POB 533
-
YOKNEAM,L3 2069206
ISR
ph: 972-4909-7470
fax: -
ir@inmodemd.com http://www.inmodemd.com
 
 • General Corporate Information   
Officers
Moshe Mizrahy - Chief Executive Officer and Chairman
Shakil Lakhani - President
Yair Malca - Chief Financial Officer
Bruce Mann - Director
Michael Anghel - Director

Peer Information
InMode Ltd. (BJCT)
InMode Ltd. (CADMQ)
InMode Ltd. (APNO)
InMode Ltd. (UPDC)
InMode Ltd. (IMTIQ)
InMode Ltd. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: M5425M103
SIC: 3845
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 07/27/22
Share - Related Items
Shares Outstanding: 83.24
Most Recent Split Date: 10.00 (2.00:1)
Beta: 2.12
Market Capitalization: $2,024.43 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/27/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: 12.44
PEG Ratio: -
Price Ratios
Price/Book: 5.02
Price/Cash Flow: 12.28
Price / Sales: 5.36
EPS Growth
vs. Year Ago Period: 14.29%
vs. Previous Quarter: -40.00%
Sales Growth
vs. Year Ago Period: 31.13%
vs. Previous Quarter: -22.27%
ROE
03/31/22 - 43.98
12/31/21 - 46.14
09/30/21 - 46.95
ROA
03/31/22 - 38.04
12/31/21 - 39.93
09/30/21 - 40.55
Current Ratio
03/31/22 - 9.13
12/31/21 - 9.07
09/30/21 - 8.17
Quick Ratio
03/31/22 - 8.63
12/31/21 - 8.66
09/30/21 - 7.81
Operating Margin
03/31/22 - 44.63
12/31/21 - 45.97
09/30/21 - 46.06
Net Margin
03/31/22 - 44.79
12/31/21 - 46.14
09/30/21 - 46.06
Pre-Tax Margin
03/31/22 - 46.72
12/31/21 - 46.99
09/30/21 - 46.68
Book Value
03/31/22 - 4.85
12/31/21 - 5.00
09/30/21 - 5.08
Inventory Turnover
03/31/22 - 2.82
12/31/21 - 2.92
09/30/21 - 2.81
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©